These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7160110)

  • 21. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis.
    Clague RB; Shaw MJ; Holt PJ
    Ann Rheum Dis; 1980 Jun; 39(3):201-6. PubMed ID: 7416811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular sensitivity to collagen in rheumatoid arthritis.
    Trentham DE; Dynesius RA; Rocklin RE; David JR
    Trans Assoc Am Physicians; 1978; 91():118-28. PubMed ID: 754387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of antibodies to type II collagen in early rheumatoid arthritis.
    Cook AD; Rowley MJ; Stockman A; Muirden KD; Mackay IR
    J Rheumatol; 1994 Jul; 21(7):1186-91. PubMed ID: 7525955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In patients with rheumatoid arthritis IgG binding to denatured collagen type II is in part mediated by IgG-fibronectin complexes.
    Mannik M; Kapil S; Merrill CE
    J Immunol; 1997 Feb; 158(3):1446-52. PubMed ID: 9013990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and synovial fluid antibodies to collagen in rheumatic diseases: a review.
    Verbruggen LA; Geerts A; Wisse E; Lapiere C
    Clin Rheumatol; 1986 Dec; 5(4):440-4. PubMed ID: 3816091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis.
    Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS
    Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagen antibodies in juvenile arthritis and adult rheumatoid arthritis: differences in levels and type-specificity.
    Rowley MJ; Gershwin ME; Mackay IR
    J Rheumatol; 1988 Feb; 15(2):289-94. PubMed ID: 3361538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
    Emmrich J; Geiler G
    Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunologic diagnosis of rheumatoid arthritis].
    Bonvoisin B
    Sem Hop; 1984 May; 60(19):1361-9. PubMed ID: 6326329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomorphological, ultrastructural and immunological particularities of the synovial fluid in seronegative rheumatoid arthritis.
    Ciobanu A; Ciobanu IR; Stoicescu M; Stroescu I; Ioniţă A; Caralicea M; Curuţ O
    Rom J Morphol Embryol; 1992; 38(3-4):129-41. PubMed ID: 1342200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
    Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
    Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to native and denatured type II collagen in children with rheumatic diseases.
    Rosenberg AM; Hunt DW; Petty RE
    J Rheumatol; 1984 Aug; 11(4):425-31. PubMed ID: 6332907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Humoral and cellular anticollagen autoimmunity in rheumatic pathology].
    Gioud M; Monier JC; Bonvoisin B; Meghlaoui A; Venet C; Lejeune E; Bouvier M
    Rev Rhum Mal Osteoartic; 1983; 50(8-9):579-83. PubMed ID: 6356308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to native type I collagen in childhood rheumatic diseases.
    Rosenberg AM; Hunt DW; Petty RE
    J Rheumatol; 1984 Aug; 11(4):421-4. PubMed ID: 6332906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis.
    Klareskog L; Johnell O; Hulth A; Holmdahl R; Rubin K
    Arthritis Rheum; 1986 Jun; 29(6):730-8. PubMed ID: 2424461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [IgG RF analysis of synovial fluid of the knee joints in 35 patients with rheumatic disease].
    Yu M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Dec; 15(6):452-4. PubMed ID: 8082257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.